Champions Oncology Ownership | Who Owns Champions Oncology?

Overview Forecast RevenueFinancials Chart Transcripts

Champions Oncology Ownership Summary

Champions Oncology is owned by 41.07% institutional investors, 26.86% insiders, and 32.07% retail investors. Battery management is the largest institutional shareholder, holding 17.56% of CSBR shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.70% of its assets in Champions Oncology shares.

CSBR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Champions Oncology	41.07%	26.86%	32.07%
Sector	Healthcare Stocks	42.54%	10.83%	46.63%
Industry	Biotech Stocks	45.22%	10.75%	44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Battery management	2.42M	17.56%	$15.68M
Nea management company	1.71M	12.43%	$11.10M
Vanguard group	333.26K	2.42%	$2.16M
Tocqueville asset management	319.67K	2.32%	$2.07M
Morgan stanley	189.60K	1.38%	$1.23M
Renaissance	167.26K	1.21%	$1.08M
Blackrock funding, inc. /de	121.91K	0.88%	$789.37K
Blackrock	116.07K	0.85%	$600.09K
Geode capital management	74.41K	0.54%	$481.91K
Northern trust	46.43K	0.34%	$300.66K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Battery management	2.42M	2.99%	$15.68M
Nea management company	1.71M	0.61%	$11.10M
Tocqueville asset management	319.67K	0.03%	$2.07M
Gsa capital partners llp	10.41K	0.01%	$67.00K
Mesirow financial investment management	12.00K	0.00%	$77.70K
Renaissance	167.26K	0.00%	$1.08M
O'shaughnessy asset management	14.47K	0.00%	$93.67K
Acadian asset management	36.18K	0.00%	$232.00K
Hightower advisors	35.16K	0.00%	$227.65K
Cambridge investment research advisors	12.25K	0.00%	$79.00K

Top Buyers

Holder	Shares	% Assets	Change
Morgan stanley	189.60K	0.00%	59.10K
Susquehanna group, llp	11.52K	-	11.52K
Vanguard group	333.26K	-	6.23K
Simplex trading	3.00K	-	1.41K
Lazard asset management	1.35K	-	1.35K

Top Sellers

Holder	Shares	% Assets	Change
Tocqueville asset management	319.67K	0.03%	-80.21K
Eam investors	-	-	-79.99K
Essex investment management	-	-	-77.20K
Goldman sachs group	-	-	-48.41K
Hillsdale investment management	-	-	-25.10K

New Positions

Holder	Shares	% Assets	Change	Value
Susquehanna group, llp	11.52K	-	11.52K	$98.76K
Lazard asset management	1.35K	-	1.35K	$9.00K
Whittier trust	800.00	0.00%	800.00	$5.04K

Sold Out

Holder	Change
Wells fargo & company/mn	-47.00
Advisor group	-100.00
Tower research capital llc (trc)	-501.00
Ubs group	-529.00
Citigroup	-4.92K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	26	-18.75%	5,663,057	-1.90%	41	2.33%	7	-46.15%	9	28.57%
Jun 30, 2025	32	-11.11%	5,772,831	-2.44%	41	2.25%	13	-35.00%	7	16.67%
Mar 31, 2025	36	38.46%	5,917,321	3.47%	43	2.44%	21	110.00%	6	100.00%
Dec 31, 2024	26	18.18%	5,718,724	-1.12%	42	2.32%	10	-9.09%	3	50.00%
Sep 30, 2024	22	-12.00%	5,783,612	0.16%	42	2.36%	11	57.14%	2	-71.43%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	235.74K	1.70%	-
Vanguard Total Stock Mkt Idx Inv	230.70K	1.67%	-5.04K
IMC US Ultra Micro Cap	88.31K	0.64%	-
Vanguard Institutional Extnd Mkt Idx Tr	63.02K	0.46%	-19.65K
Pleiades Small Cap Equity A	44.16K	0.32%	44.16K
Fidelity Extended Market Index	32.19K	0.23%	-265.00
iShares Micro-Cap ETF	20.31K	0.15%	-
Fidelity Total Market Index	12.21K	0.09%	-26.00
BlackRock Extended Equity Market K	11.17K	0.08%	-5.00
Fidelity Nasdaq Composite Index	10.96K	0.08%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 12, 2024	Mendelson Daniel Newman	-	Buy	$6.50K
Jan 11, 2024	Mendelson Daniel Newman	-	Buy	$12.54K
Jan 10, 2024	Mendelson Daniel Newman	-	Buy	$18.58K
Jan 09, 2024	Mendelson Daniel Newman	-	Buy	$18.75K
Jan 08, 2024	Mendelson Daniel Newman	-	Buy	$6.15K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	-
2025 Q1	-	-
2024 Q4	-	-
2024 Q1	8	-
2023 Q4	9	-

CSBR Ownership FAQ

Who Owns Champions Oncology?

Champions Oncology shareholders are primarily institutional investors at 41.07%, followed by 26.86% insiders and 32.07% retail investors. The average institutional ownership in Champions Oncology's industry, Biotech Stocks , is 45.22%, which Champions Oncology falls below.

Who owns the most shares of Champions Oncology?

Champions Oncology’s largest shareholders are Battery management (2.42M shares, 17.56%), Nea management company (1.71M shares, 12.43%), and Vanguard group (333.26K shares, 2.42%). Together, they hold 32.41% of Champions Oncology’s total shares outstanding.

Does Blackrock own Champions Oncology?

Yes, BlackRock owns 0.85% of Champions Oncology, totaling 116.07K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 600.09K$. In the last quarter, BlackRock increased its holdings by 389 shares, a 0.34% change.

Who is Champions Oncology’s biggest shareholder by percentage of total assets invested?

Battery management is Champions Oncology’s biggest shareholder by percentage of total assets invested, with 2.99% of its assets in 2.42M Champions Oncology shares, valued at 15.68M$.

Who is the top mutual fund holder of Champions Oncology shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Champions Oncology shares, with 1.70% of its total shares outstanding invested in 235.74K Champions Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools